Recombinant Human Thrombospondin-3 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8390-TH
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-linked oligomer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human Thrombospondin-3 protein
Ser22-Val956 with a C-terminal 10-His tag
Ser22-Val956 with a C-terminal 10-His tag
Purity
>90%, by SDS-PAGE with silver staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ser22
Predicted Molecular Mass
103 kDa
SDS-PAGE
100-145 kDa, reducing conditions
Activity
Measured by its ability to induce adhesion of ATDC5 mouse chondrogenic cells.
The ED50 for this effect is 0.3-1.5 μg/mL.
The ED50 for this effect is 0.3-1.5 μg/mL.
Formulation, Preparation and Storage
8390-TH
Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate, NaCl and CHAPS. |
Reconstitution |
Reconstitute at 200 μg/mL in sterile PBS.
|
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Thrombospondin-3
References
- Murphy-Ullrich, J.E. and R.V. Iozzo (2012) Matrix Biol. 31:152.
- Adolph, K.W. et al. (1995) Genomics 27:329.
- Qabar, A. et al. (1995) J. Biol. Chem. 270:12725.
- Iruela-Arispe, M.L. et al. (1993) Dev. Dyn. 197:40.
- Qabar, A. et al. (1994) J. Biol. Chem. 269:1262.
- Vos, H.L. et al. (1992) J. Biol. Chem. 267:12192.
- Posey, K.L. et al. (2008) Am. J. Pathol. 172:1664.
- Dalla-Torre, C.A. et al. (2006) BMC Cancer 6:237.
- Armstrong, D.J. et al. (2002) Int. J. Biochem. Cell Biol. 34:588.
Alternate Names
THBS3, Thrombospondin3, TSP3
Gene Symbol
THBS3
UniProt
Additional Thrombospondin-3 Products
Product Documents for Recombinant Human Thrombospondin-3 Protein, CF
Product Specific Notices for Recombinant Human Thrombospondin-3 Protein, CF
For research use only
Loading...
Loading...
Loading...